Cargando…
Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical Implementation
Severe cutaneous adverse reactions (SCARs), previously thought to be idiosyncratic or unpredictable, are a deadly form of adverse drug reactions with skin manifestations. Current pharmacogenomic studies of SCARs have made important strides, as the prevention of SCARs, to some extent, appears attaina...
Autores principales: | Su, Shih-Chi, Hung, Shuen-Iu, Fan, Wen-Lang, Dao, Ro-Lan, Chung, Wen-Hung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133889/ https://www.ncbi.nlm.nih.gov/pubmed/27854302 http://dx.doi.org/10.3390/ijms17111890 |
Ejemplares similares
-
Recent advances of pharmacogenomics in severe cutaneous adverse reactions: immune and nonimmune mechanisms
por: Dao, Ro-Lan, et al.
Publicado: (2015) -
Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
por: Chang, Chih-Jung, et al.
Publicado: (2020) -
Digging Up the Human Genome: Current Progress in Deciphering Adverse Drug Reactions
por: Su, Shih-Chi, et al.
Publicado: (2014) -
Cytotoxic Proteins and Therapeutic Targets in Severe Cutaneous Adverse Reactions
por: Su, Shih-Chi, et al.
Publicado: (2014) -
The role of genetic variants in human longevity
por: Chung, Wen-Hung, et al.
Publicado: (2010)